Press release
Non-Therapeutic Biomolecules Market Insights Highlight Segment Expansion And Market Leadership
Non-Therapeutic Biomolecules
Non-Therapeutic Biomolecules Market Size and Growth Forecast Through 2030
The market for non-therapeutic biomolecules has experienced rapid growth and is anticipated to continue this trajectory. From a valuation of $33.92 billion in 2025, it is projected to rise to $37.59 billion in 2026, reflecting a compound annual growth rate (CAGR) of 10.8%. This surge during the historic period has been fueled by increased demand for research biomolecules, wider adoption in in vitro diagnostics, expansion in pharmaceutical R&D, progress in recombinant protein technologies, and enhanced collaboration among biotech companies.
Looking ahead, the market is expected to reach $56.43 billion by 2030, maintaining a CAGR of 10.7%. This anticipated growth is attributed to the broadening use of synthetic biomolecules, rising investments in precision medicine, expanding applications in agricultural biotechnology, growing emphasis on sustainable production methods, and the rise of automated biomolecule synthesis platforms. Key trends projected to shape the market include innovations in protein engineering, advanced high-throughput screening techniques, eco-friendly biomolecule generation, cell-free synthesis processes, and customizable biomolecule platforms.
Download a free sample of the non-therapeutic biomolecules market report:
https://thebusinessresearchcompany.com/sample_request?id=57402104&type=smp&name=Non-Therapeutic%20Biomolecules%20Market%20Report%202026&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Oct_PR
Key Factors Influencing Growth in the Non-Therapeutic Biomolecules Market
The increased demand for sophisticated research biomolecules has played a crucial role in driving the market's expansion. Enhanced requirements in pharmaceutical and biotech research, coupled with technological advances in recombinant proteins, have significantly boosted market growth.
Additionally, ongoing collaborations between biotechnology firms and research institutions are accelerating development and adoption of novel biomolecules, further fueling market momentum.
Top Companies Leading the Non-Therapeutic Biomolecules Market
This market is shaped by numerous prominent players including Amgen Inc., Genentech Inc., Merck KGaA, Lonza Group AG, Bio-Rad Laboratories Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., Charles River Laboratories International Inc., GE Healthcare Life Sciences, Fujifilm Diosynth Biotechnologies, Evonik Industries AG, Seikagaku Corporation, Takeda Pharmaceutical Company Limited, MilliporeSigma, Covance Inc., Sartorius AG, Sanofi S.A., CordenPharma International, Bayer AG, WuXi AppTec, Ginkgo Bioworks, Eppendorf AG, Bio-Techne Corporation, Vectalys, and Avid Bioservices Inc.
A notable recent development occurred in December 2023 when Danaher Corporation, a US-based conglomerate specializing in life sciences and diagnostics equipment, acquired Abcam plc. This acquisition aims to expand Danaher's portfolio in non-therapeutic biomolecules by incorporating Abcam's extensive range of antibodies, proteins, and immunoassay products into its global distribution and solutions network. Abcam plc is a UK-based leader supplying research-use antibodies, proteins, immunoassays, and other reagents essential for drug discovery, diagnostics, and academic research.
View the full non-therapeutic biomolecules market report:
https://www.thebusinessresearchcompany.com/report/non-therapeutic-biomolecules-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Oct_PR
Innovative Trends Shaping the Non-Therapeutic Biomolecules Sector
A prominent focus within the market is the development of advanced cell separation technologies designed to increase throughput and optimize laboratory workflows. These innovations provide scientists with crucial solutions to complex biological and research challenges.
For example, in May 2023, AcouSort AB, a biotechnology company from Sweden, introduced the AcouTrap 3 system. This platform uniquely combines acoustofluidics-integrating sound waves with microfluidics-to streamline the isolation of cells and extracellular vesicles in a single process. Utilizing gentle acoustic trapping technology, the system allows processing of larger sample volumes with higher cell viability and minimal losses compared to conventional column- or bead-based methods, enhancing productivity and efficiency in laboratory operations.
Detailed Segmentation of the Non-Therapeutic Biomolecules Market
The report categorizes the non-therapeutic biomolecules market based on several key parameters:
1) By Biomolecule Type:
- Enzymes
- Recombinant Proteins
- Plasmids
- Peptides
- Oligonucleotides
- Monoclonal Antibodies
2) By End User Segment:
- Research
- Pharmaceutical
- In Vitro Diagnostics (IVD)
3) By Application Area:
- Diagnostic Equipment
- Therapeutic Equipment
- Monitoring or Imaging Equipment
- Laboratory or Research Equipment
- Rehabilitation or Mobility Support
Subcategories feature:
- Enzymes divided into industrial enzymes and diagnostic enzymes;
- Recombinant proteins including antigens, cytokines, and growth factors;
- Plasmids split into research plasmids and expression plasmids;
- Peptides categorized as antimicrobial and signaling peptides;
- Oligonucleotides covering antisense and RNA interference oligonucleotides;
- Monoclonal antibodies comprising research and diagnostic antibodies.
This comprehensive segmentation provides detailed insights into market demand and application areas, supporting strategic decision-making for investors and industry participants.
Our latest 2026 market reports provide expanded strategic and visual intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, together with updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Non-Therapeutic Biomolecules Market Insights Highlight Segment Expansion And Market Leadership here
News-ID: 4672819 • Views: …
More Releases from The Business Research Company
Oncogene Inhibitor Market Outlook Highlights Strategic Opportunities Across The …
The oncogene inhibitor market has witnessed significant growth over recent years, driven by advancements in cancer treatment and rising awareness of targeted therapies. As research and development continue to push boundaries, this sector is poised for strong expansion in the coming years. Let's explore the current market size, key factors fueling growth, prominent players, emerging trends, and detailed segment insights shaping the global oncogene inhibitor landscape.
Oncogene Inhibitor Market Size and…
Octreotide Market Research Reveals Path To $3.26 Billion By 2030
The octreotide market has shown consistent growth over recent years, driven by advances in medical treatments and increasing awareness of related health conditions. As demand for effective therapies rises, this market is set to experience steady expansion, supported by innovations and a broader range of clinical applications. Below, we explore the current market size, key players, growth drivers, emerging trends, and segmentation details.
Projected Growth and Size of the Octreotide Market…
Nucleotides Supplements Market Outlook Signals Expansion To $4.74 Billion Throug …
An increasing awareness surrounding cellular nutrition and advancements in nutraceutical manufacturing are driving significant interest in the nucleotides supplements market. As consumer demand grows in both human and animal nutrition sectors, the market is poised for substantial growth. Let's explore the current market value, key players, emerging trends, and major segments shaping the nucleotides supplements industry.
Market Size and Growth Trajectory of the Nucleotides Supplements Market
The nucleotides supplements market has…
Non-Alcoholic Steatohepatitis Treatment Market Report Provides Insights Into Mar …
The treatment landscape for non-alcoholic steatohepatitis (NASH) is evolving rapidly, reflecting a growing focus on addressing this serious liver condition. With rising awareness, medical advancements, and increasing investment, the market for NASH therapies is set to expand significantly in the coming years. Here's a detailed overview of the market's size, driving factors, key players, and emerging trends.
Non-Alcoholic Steatohepatitis Treatment Market Size and Growth Forecast
The market value for non-alcoholic steatohepatitis…
More Releases for Biomolecule
Capillary Electrophoresis Market Expected to Hit US$ 611.25 Million by 2033 as D …
DataM Intelligence has released a new research report titled "Capillary Electrophoresis Market Size 2026". The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms…
Robust Growth in Biomolecule Fractionation Technologies Market (2025-2032): Indu …
A newly released report on the "Biomolecule Fractionation Technologies Market 2025" provides a comprehensive view of the industry with market insights on the competitive scenarios and market segments with complete representation through graphs, tables, and charts to study the market easy to use and compare the numbers and user-friendly. The Biomolecule Fractionation Technologies Market research report is the hub of market information, which precisely expounds on critical challenges and future…
Global Spin Desalting Columns Market Poised for Robust Growth in Rapid Protein a …
The global spin desalting columns market is entering a phase of accelerated expansion as biopharmaceutical research, personalized medicine initiatives, and high-throughput proteomics workflows drive unprecedented demand for rapid, reliable buffer exchange and desalting solutions. Recent industry analysis reveals that researchers and quality-control laboratories worldwide are increasingly adopting spin column formats to accelerate sample preparation, minimize protein loss, and streamline workflows-trends that are expected to fuel market growth through 2030.
Get a…
Amerigo Scientific Announced Chromatography Media Ideal for Biomolecule Purifica …
Amerigo Scientific recently announced the collaboration with ISO 9001-certified manufacturers to distribute a wide range of chromatography media products.
New York, USA - November 14, 2024 - Amerigo Scientific recently announced the collaboration with ISO 9001-certified manufacturers to distribute a wide range of chromatography media products covering solid phase extraction adsorbents, silica gel, and resins. These chromatography media are manufactured with a proprietary production process, specializing in affinity, hydrophobic interaction, ion…
CD Bioparticles Announces Versatile Basic Agarose Particles for Efficient Biomol …
CD Bioparticles announces new line of Basic Agarose Particles for efficient biomolecule separation.
With years of experience in the pharmaceutical and life science sectors, CD Bioparticles announces the availability of its new line of Basic Agarose Particles [https://www.cd-bioparticles.com/products/basic-agarose-particles-1064.html] for efficient biomolecule separation. These versatile, unmodified agarose microspheres offer researchers a powerful tool for various applications, including protein purification, negative controls in experiments, and the foundation for further functionalization.
Basic agarose particles are…
Cell Isolation Industry To Observe Fastest Growth In Biomolecule Isolation Categ …
According to a statement by P&S Intelligence, the cell isolation market was USD 9,845.7 million in 2022, and it will reach USD 34,746.3 million, progressing at a compound annual growth rate of 17.1%, by 2030.
The growth of the industry is attributed to the increasing requirement for biopharmaceuticals, rising research on personalized medicine, and growing government investment in cell-based research.
Download free sample pages of this report: https://www.psmarketresearch.com/market-analysis/cell-isolation-market/report-sample
In 2022, the centrifugation…
